{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:08:54Z","timestamp":1793686134911,"version":"4.5.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lung disease is common in patients with rheumatoid arthritis (RA). The onset of lung involvement in RA is not well known. The objective is to describe the features and evolution of lung involvement in early RA, its relationship with disease activity parameters, smoking and treatments. Consecutive patients with early RA without respiratory symptoms were included and tracked for 5\u00a0years. Lung assessment included clinical, radiological and pulmonary function tests at diagnosis and during follow-up. Peripheral blood parameters (erythrocyte sedimentation rate, C reactive protein, rheumatoid factor and anti-citrullinated peptide autoantibodies) and scales of articular involvement, such as DAS28-CRP, were evaluated. 40 patients were included and 32 completed the 5-year follow up. 13 patients presented lung involvement in the initial 5\u00a0years after RA diagnosis, 3 of them interstitial lung disease. Significant decrease of diffusion lung transfer capacity of carbon monoxide over time was observed in six patients, 2 of them developed interstitial lung disease. DLCO decrease was correlated with higher values of CRP and ESR at diagnosis. Methotrexate was not associated with DLCO deterioration or lung disease development. Subclinical progressive lung disease correlates with RA activity parameters. Smoking status and methotrexate were not associated with development or progression of lung disease.<\/jats:p>","DOI":"10.1038\/s41598-020-72768-z","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T10:04:50Z","timestamp":1600941890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A prospective study of lung disease in a cohort of early rheumatoid arthritis patients"],"prefix":"10.1038","volume":"10","author":[{"given":"A.","family":"Robles-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Luburich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bolivar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Nolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Molina-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Narv\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"issue":"380","key":"72768_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","volume":"2012","author":"A Fischer","year":"2012","unstructured":"Fischer, A. & du Bois, R. Interstitial lung disease in connective tissue disorders. Lancet 2012(380), 689\u2013698 (2012).","journal-title":"Lancet"},{"key":"72768_CR2","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.chest.2017.05.015","volume":"152","author":"TJ Doyle","year":"2017","unstructured":"Doyle, T. J. & Dellaripa, P. F. Lung manifestations in the rheumatic diseases. Chest 152, 1283\u20131295 (2017).","journal-title":"Chest"},{"key":"72768_CR3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz, T. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 62, 1583\u20131591 (2010).","journal-title":"Arthritis Rheum."},{"key":"72768_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/1479972315620746","volume":"13","author":"A Robles-Perez","year":"2016","unstructured":"Robles-Perez, A. et al. Preclinical lung disease in early rheumatoid arthritis. Chron. Respir. Dis. 13, 75\u201381 (2016).","journal-title":"Chron. Respir. Dis."},{"key":"72768_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","volume":"30","author":"HM Habib","year":"2011","unstructured":"Habib, H. M., Eisa, A. A., Arafat, W. R. & Marie, M. A. Pulmonary involvement in early rheumatoid arthritis patients. Clin. Rheumatol. 30, 217\u2013221 (2011).","journal-title":"Clin. Rheumatol."},{"key":"72768_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3899\/jrheum.131341","volume":"41","author":"J Zhu","year":"2014","unstructured":"Zhu, J., Zhou, Y., Chen, X. & Li, J. A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. J. Rheumatol. 41, 1282\u20131289 (2014).","journal-title":"J. Rheumatol."},{"key":"72768_CR7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.rmed.2012.06.020","volume":"106","author":"M Wilsher","year":"2012","unstructured":"Wilsher, M. et al. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir. Med. 106, 1441\u20131446 (2012).","journal-title":"Respir. Med."},{"key":"72768_CR8","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.40904","volume":"71","author":"JA Sparks","year":"2019","unstructured":"Sparks, J. A. et al. Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study. Arthritis Rheumatol. 71, 1472\u20131482 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"72768_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/14712598.2017.1287169","volume":"17","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies. Expert Opin. Biol. Ther. 17, 265\u2013283 (2017).","journal-title":"Expert Opin. Biol. Ther."},{"key":"72768_CR10","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","volume":"36","author":"J Rojas-Serrano","year":"2017","unstructured":"Rojas-Serrano, J. et al. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Clin. Rheumatol. 36, 1493\u20131500 (2017).","journal-title":"Clin. Rheumatol."},{"key":"72768_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett, F. C. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315\u2013324 (1988).","journal-title":"Arthritis Rheum."},{"key":"72768_CR12","volume-title":"Manual SEPAR de Procedimientos 3: Evaluaci\u00f3n de la funci\u00f3n pulmonar","author":"LP Maetsu","year":"2002","unstructured":"Maetsu, L. P. Manual SEPAR de Procedimientos 3: Evaluaci\u00f3n de la funci\u00f3n pulmonar (Luz\u00e1n 5, S.A. de Ediciones, Madrid, 2002)."},{"key":"72768_CR13","unstructured":"Cinical Practice Guideline: Rheumatoid Arthritis\u2014Adult. Version 1.1.2016. United Rheumatology (2016)."},{"key":"72768_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10067-017-3561-5","volume":"36","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Li, H., Wu, N., Dong, X. & Zheng, Y. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin. Rheumatol. 36, 817\u2013823 (2017).","journal-title":"Clin. Rheumatol."},{"key":"72768_CR15","first-page":"76","volume":"70","author":"F Paulin","year":"2018","unstructured":"Paulin, F. et al. Correlation between lung and joint involvement in patients with rheumatoid arthritis and interstitial lung disease: a cross-sectional study. Rev. Investig. Clin. 70, 76\u201381 (2018).","journal-title":"Rev. Investig. Clin."},{"key":"72768_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"BR Gochuico","year":"2008","unstructured":"Gochuico, B. R. et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch. Intern. Med. 168, 159\u2013166 (2008).","journal-title":"Arch. Intern. Med."},{"key":"72768_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1136\/thoraxjnl-2016-208932","volume":"71","author":"EJ Bernstein","year":"2016","unstructured":"Bernstein, E. J. et al. Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis. Thorax 71, 1082\u20131090 (2016).","journal-title":"Thorax"},{"key":"72768_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","volume":"15","author":"S Imokawa","year":"2000","unstructured":"Imokawa, S., Colby, T. V., Leslie, K. O. & Helmers, R. A. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur. Respir. J. 15, 373\u2013381 (2000).","journal-title":"Eur. Respir. J."},{"key":"72768_CR19","first-page":"S918","volume":"64","author":"R Conway","year":"2012","unstructured":"Conway, R., Low, C., Coughlan, R. J., O\u2019Donell, M. J. & Carey, J. J. Methotrexate and interstitial lung disease in rheumatoid arthritis\u2014a systematic literature review and meta-analysis. Arthritis Rheum. 64, S918 (2012) ((abstract)).","journal-title":"Arthritis Rheum."},{"key":"72768_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.38322","volume":"66","author":"R Conway","year":"2014","unstructured":"Conway, R., Low, C., Coughlan, R. J., O\u2019Donell, M. J. & Carey, J. J. Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum. 66, 803\u2013812 (2014).","journal-title":"Arthritis Rheum."},{"key":"72768_CR21","doi-asserted-by":"publisher","first-page":"h1269","DOI":"10.1136\/bmj.h1269","volume":"350","author":"R Conway","year":"2015","unstructured":"Conway, R., Low, C., Coughlan, R. J., O\u2019Donell, M. J. & Carey, J. J. Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials. BMJ 350, h1269 (2015).","journal-title":"BMJ"},{"key":"72768_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"HK Choi","year":"2002","unstructured":"Choi, H. K., Hern\u00e1n, M. A., Seeger, J. D., Robins, J. M. & Wolfe, F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359, 1173\u20131177 (2002).","journal-title":"Lancet"},{"key":"72768_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/art.37723","volume":"65","author":"MC Wasko","year":"2013","unstructured":"Wasko, M. C., Dasgupta, A., Hubert, H., Fries, J. F. & Ward, M. M. Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum. 65, 334\u2013342 (2013).","journal-title":"Arthritis Rheum."},{"key":"72768_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"E Gabbay","year":"2008","unstructured":"Gabbay, E. et al. Interstitial lung disease in recent onset rheumatoid arthritis. Arch. Intern. Med. 168, 159\u2013166 (2008).","journal-title":"Arch. Intern. Med."},{"key":"72768_CR25","first-page":"1513","volume":"35","author":"S Mori","year":"2008","unstructured":"Mori, S., Cho, I., Koga, Y. & Sugimoto, S. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J. Rheumatol. 35, 1513\u20131521 (2008).","journal-title":"J. Rheumatol."},{"key":"72768_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/03009740701393957","volume":"36","author":"ZM Metafratzi","year":"2007","unstructured":"Metafratzi, Z. M. et al. Pulmonary involvement in patients with early rheumatoid arthritis. Scand. J. Rheumatol. 36, 338\u2013344 (2007).","journal-title":"Scand. J. Rheumatol."},{"key":"72768_CR27","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.chest.2016.12.024","volume":"151","author":"A De Soyza","year":"2017","unstructured":"De Soyza, A. et al. Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study. Chest 151, 1247\u20131254 (2017).","journal-title":"Chest"},{"key":"72768_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/1479972310391282","volume":"8","author":"HK Ong","year":"2011","unstructured":"Ong, H. K., Lee, A. L., Hill, C. J., Holland, A. E. & Denehy, L. Effects of pulmonary rehabilitation in bronchiectasis: a retrospective study. Chron. Respir. Dis. 8, 21\u201330 (2011).","journal-title":"Chron. Respir. Dis."},{"key":"72768_CR29","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","volume":"49","author":"G Koduri","year":"2010","unstructured":"Koduri, G. et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology 49, 1483\u20131489 (2010).","journal-title":"Rheumatology"},{"key":"72768_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","volume":"46","author":"A Young","year":"2007","unstructured":"Young, A. et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology 46, 350\u2013357 (2007).","journal-title":"Rheumatology"},{"key":"72768_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson, A. L. et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am. J. Res. Crit. Care Med. 183, 372\u2013378 (2011).","journal-title":"Am. J. Res. Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72768-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:25:15Z","timestamp":1670354715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72768-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72768"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72768-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"assertion":[{"value":"15 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15640"}}